MedTrace Logo

Effect of a Low Starch Diet in Patients With Ankylosing Spondylitis

NCT04386538 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-01-25

No results posted yet for this study

Summary

The aim of this study is to explore the effect of a low starch diet (reduction of at least 40%) in the gut bacteria modulation, especially Klebsiella pneumoniae, and its relation to disease activity, functional impairment and quality of life in patients with Ankylosing Spondylitis (AS).

Conditions

Interventions

BEHAVIORAL

Low Starch Diet (LSD)

6-week balanced diet program, adapted to individual energetic needs, with significant reduction of high content starchy food, naturally present in plant cells, roots, tubers, seeds, beans, legumes, fruits, and highly present in most farinaceous grains, especially in potatoes, corn, rice, pasta, bread, cookies and cakes.

BEHAVIORAL

General healthy eating

6-week balanced healthy eating counseling program, according to the World Health Organization recommendations.

Sponsors & Collaborators

  • Portuguese Institute of Rheumatology

    collaborator UNKNOWN

  • Centro de Investigação Interdisciplinar Egas Moniz

    collaborator UNKNOWN

  • Universidade do Porto

    lead OTHER

Principal Investigators

  • Alexandra MT Cardoso, MD · Universidade do Porto

  • Maria Leonor Silva, PhD · Centro de Investigação Interdisciplinar Egas Moniz

  • Patrícia Padrão, PhD · Universidade do Porto

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-03
Primary Completion
2022-09-30
Completion
2022-12-30

Countries

  • Portugal

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04386538 on ClinicalTrials.gov